We serve Chemical Name:4-BROMOCATECHOL CAS:17345-77-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-BROMOCATECHOL
CAS.NO:17345-77-6
Synonyms:1,2-Benzendiol, 4-bromo-;4-BROMOCATECHOL;4-Bromobenzene-1,2-diol;1,2-Benzenediol, 4-bromo-;EINECS 241-370-5;4-Bromo-1,2-benzenediol;4-Bromo-1,2-dihydroxybenzene
Molecular Formula:C6H5BrO2
Molecular Weight:189.007
HS Code:2908199090
Physical and Chemical Properties:
Melting point:87ºC
Boiling point:280.5±20.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.657
PSA:40.46000
Exact Mass:187.947281
LogP:2.26
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,2-Benzendiol, 4-bromo- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Bromo-1,2-dihydroxybenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-BROMOCATECHOL Use and application,1,2-Benzenediol, 4-bromo- technical grade,usp/ep/jp grade.
Related News: A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. 3-cyclopropyl-1-methyl-4-(2-(methylthio)-4-nitrobenzoyl)-1H-pyrazol-5-yl 4-methylbenzenesulfonate manufacturers The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. 2-(2-Chloro-benzyloxy)-1-methyl-3,5-dinitro-benzene suppliers But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals. 2-methyl-cyclohexane-1,3-dione dioxime vendor & factory But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals.,For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains.
